T2D-associated exosomes induce ER stress and metabolic reprogramming in tumor CD8+T cellsJOURNAL OF IMMUNOLOGYIF3.42025-11-010PRE
Diabetic exosomes reprogram tumor-T cell crosstalk to promote immune evasion in breast cancer patient-derived organoidsJOURNAL OF IMMUNOLOGYIF3.42025-11-010PRE
Unlocking the potential of dimethyl fumarate: enhancing oncolytic HSV-1 efficacy for wider cancer applicationsFRONTIERS IN IMMUNOLOGYIF5.92023-12-192OAAI
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVA51 oncolytic virotherapyMOLECULAR THERAPYIF122023-11-017OAAI
Occlusal Force Maintains Alveolar Bone Homeostasis via Type H AngiogenesisJOURNAL OF DENTAL RESEARCHIF5.92023-10-0315PRE
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOXFRONTIERS IN IMMUNOLOGYIF5.92023-01-136OAAI
Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokinesFRONTIERS IN IMMUNOLOGYIF5.92022-11-285OAAI
An infrared spectral biomarker accurately predicts neurodegenerative disease class in the absence of overt symptomsSCIENTIFIC REPORTSIF3.92021-08-0210OAAI
Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer ImmunotherapyMOLECULAR THERAPY-ONCOLYTICSIF02020-12-012OAAI
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergyCOMMUNICATIONS BIOLOGYIF5.12020-05-2212OAAI
Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription用小分子稳定Max同源二聚体可减弱Myc驱动的转录CELL CHEMICAL BIOLOGYIF7.22019-05-01111OAAI
Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibitionSCIENCE TRANSLATIONAL MEDICINEIF14.62018-01-2443OAAI
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium CompoundsMOLECULAR THERAPYIF122018-01-0174OAAI
Oncolytic Maraba Virus MG1 as a Treatment for SarcomaINTERNATIONAL JOURNAL OF CANCERIF4.72017-06-2137OAAI
First-in-class small molecule potentiators of cancer virotherapySCIENTIFIC REPORTSIF3.92016-05-2625OAAI
Dosing schedule effects on combination activity from first principlesCANCER RESEARCHIF16.62015-08-010PRE
Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killingNATURE COMMUNICATIONSIF15.72015-03-3053OAAI
Variability in xenograft growth rates can be explained by intra-tumor evolutionary dynamicsCANCER RESEARCHIF16.62014-10-010PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向